Moreover, while the mechanism of adenocarcinoma transformation is relatively well understood, the mechanism by which ASC transforms into a neuroendocrine carcinoma following EGFR-TKI treatment remains to be further explored. The gene discussed is EGFR; the disease is adenocarcinoma.